Previous 10 | Next 10 |
The following slide deck was published by Natera, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: Natera, Inc. 2022 Q1 - Results - Earnings Call Presentation
Natera, Inc. (NTRA) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman - Chief Executive Officer Solomon Moshkevich - General Manager, Oncology Conference Call Participants Tejas Savant - Morgan Stanley Stephani...
Natera (NTRA) rallies 4% premarket as the Co. reported Q1 revenues of $194.1M beating estimates by $17.5M, where Product revenues were $190M, an increase of 57.8% Y/Y. The Co. processed ~489,300 tests in Q1 2022, compared to ~348,200 tests processed in Q1 2021, an increase of 40.5% ...
Natera press release (NASDAQ:NTRA): Q1 GAAP EPS of -$1.45 beats by $0.04. Revenue of $194.13M (+27.5% Y/Y) beats by $17.52M. For further details see: Natera GAAP EPS of -$1.45 beats by $0.04, revenue of $194.13M beats by $17.52M
Natera Reports First Quarter 2022 Financial Results PR Newswire AUSTIN, Texas , May 5, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 3...
Natera Announces First Quarter 2022 Earnings Conference Call PR Newswire AUSTIN, Texas , May 2, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its first ...
Morgan Stanley issued its list of comprehensive top analyst picks for North America by sector Friday, with those stocks showing a median upside of 32% compared to analysts' base case price targets. Analysts can choose an Overweight or Underweight stock as their highest conviction choice in th...
New York, New York--(Newsfile Corp. - April 29, 2022) - Levi & Korsinsky, LLP notifies investors in Natera, Inc. ("Natera" or the "Company") (NASDAQ: NTRA) of a class action securities lawsuit. The lawsuit on behalf of Natera investors has been commenced in the the United States Distric...
Securities Litigation Partner Lubna M. Faruqi Encourages Investors Who Suffered Losses Exceeding $100,000 In Natera To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 28, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is inv...
NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Natera, Inc. ("Natera" or the "Company") (NASDAQ:NTRA) and reminds investors of the June 27, 2022 deadline to seek the role of lead plain...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...